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SPOTLIGHT
Arieh Gertler in his Laboarory where  every day there is the 
possibility of making a new and exciting discovery.
Arieh Gertler: 
THE KING OF HEURISTICS IN  
(ADIPO)PHARMACOLOGY
Born in Lublin, Poland in 1935, emigrated to Israel in 1950, 
served in the Israeli Defence Army in 1953-1955, graduated 
summa cum laude his BSc and MSc degree from the Faculty 
of Agriculture, Hebrew University of Jerusalem (HUJ), 
Rehovot in 19561961, Assistant Professor in the Department 
of Agricultural Biochemistry, Faculty of Agriculture in 
19611965, awarded PhD degree in 1965, Postdoctoral 
fellow in the Department of Biochememistry, University 
of Toronto Medical School, Toronto, Canada in 19651966, 
Lecturer of Agricultural Biochemistry, Faculty of Agriculture, 
HUJ, Rehovot in 19661970,  Visitng Scientist in University  of 
Toronto Medical School, Toronto, Canada in 1969, Visiting 
Associate Professor, Department of Biochemistry, University 
of Washington Medical School, Seattle, Washington, USA 
in 19721973, Visiting Associate Professor, Department of 
Human Genetics, Yale University, New Haven, CT, USA, also 
Visitng Scientist in NIH, Bethesda, USA, in the last 41 years was 
teaching an undergraduate courses in Biochemistry, Human 
Nutrition and  Molecular Endocrinology and supervised 48 MSc 
and 32 PhD students, in brief, more than 50 years of passionate 
commitment in research and education, that is, Professor 
ARIEH GERTLER, one of the chief protagonists of the current 
episode in history of pharmacobiochemistry. He was awared 
Rector’s Prize-2002 for the Best Teacher, Best Researcher 
in the Hebrew University of Jerusalem and Kaye Award for 
Innovative Research-2009, and in 2012  elected Honorary 
Member of the Bulgarian Society for Cell Biology.
In 1990-1992 Dr Gertler was Director of Department of 
Biochemistry and Human Nutrition,  Faculty of Agriculture, 
HUJ, Rehovot, in 1993 Director, School of Nutritional and 
Domestic Sciences, Faculty of Agriculture, HUJ, Rehovot, in 
1993- 1996 Director of Institute of Biochemistry, Food Science 
and Nutrition, Faculty of Agriculture, HUJ, Rehovot, in 2001-
2007 Director of the Diagnostic System Laboratories (DSL) 
Ltd (Israel), 2003-now Founder, Director and Chief executive 
o!cer of Protein Laboratories Rehovot (PLR) Ltd. 
Dr Gertler has published over 270 peer-reviewed papers 
and reviews in the "elds of enzymology, animal nutrition, 
molecular endocrinology and biotechnology.
Until 1980 his research was mainly aimed at elucidation 
of the mechanism of action of proteolytic enzymes and their 
naturally occurring inhibitors. During the last 26 years, the main 
research interests of his Laboratory were changed in direction 
of molecular biology, endocrinology and adipopharmacology. 
These included: (i) hormonal control of development and 
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King pinguins: living in peace beauty of Mother Nature.
di!erentiation of bovine mammary gland, (ii) puri"cation and 
characterization of prolactin receptors from various organs of 
lactating cow and from Nb2 lymphoma cells, (iii) cloning of 
prolactin and growth hormone receptors extracellular domains, 
(iv) investigation of the mitogenic e!ect of prolactin using Nb2 
lymphoma cells as a model, (v) investigation of structurefunction 
relationship of human and "sh growth hormones and bovine 
and ovine placental lactogen by sitedirected mutagenesis using 
recombinant DNA methodology, and (vi) preparation of leptin 
from several species of farm animals (sheep, cow, pig, rat and 
chicken). More recently, Gertler’s Laboratory intitiated study 
investigating protein-protein interaction in living cells using 
#uorescence resonance energy transfer (FRET) methodology. 
His recent "ndings are demonstarting leptin’s ability to 
transactivate erbB2 oncogenic receptor and thus showing a 
putative molecular link between obesity and breast cancer. 
During the last 19 years an extensive experience in cloning 
and puri"cation of native and recombinant proteins was 
accumulated and over 400 di!erent recombinant proteins or 
their mutated analogues were prepared in Gertler’s Laboratory, 
also  in collaboration with many Laboratories  from USA, 
Canada, France, England, Germany, Belgium, Poland, Thailand, 
Japan, Australia and New Zealand.  
Remarkably, Arieh Gertler’s present projects carried out in 
his Laboratory include:
(i) development of leptin, interleukin 22, resistin and 
prolactin antagonists using site directed mutagenesis and 
their use as potential drugs in in#ammatory and autoimmune 
diseases, cancer, uremic cachexia, metabolic syndrome and 
type 2 diabetes, and (ii) transactivation of erbB oncogenic 
receptors by leptin and prolactin and its relevance to breast 
cancer. In December 2015, Arieh Gertler and his wife Anna 
visited the Falkland Islands and South Georgia island, also 
sub-Antarctic islands, where the colourful King penguins  live 
on (Phtograph 2 taken by Arieh).
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